Data availability
Not applicable.
References
Decaux G, Soupart A, Vassart G (2008) Non-peptide arginine-vasopressin antagonists: the vaptans. Lancet 371(9624):1624–1632. https://doi.org/10.1016/S0140-6736(08)60695-9
Adrogué HJ, Tucker BM, Madias NE (2022) Diagnosis and management of hyponatremia: a review. JAMA 328(3):280–291. https://doi.org/10.1001/jama.2022.11176
Verbalis JG (2006) Whole-body volume regulation and escape from antidiuresis. Am J Med 119(7 Suppl 1):S21–S29. https://doi.org/10.1016/j.amjmed.2006.05.004
Ecelbarger CA, Nielsen S, Olson BR et al (1997) Role of renal aquaporins in escape from vasopressin-induced antidiuresis in rat. J Clin Invest 99(8):1852–1863. https://doi.org/10.1172/JCI119352
Tanemoto M (2023) Vaptans for hyponatraemia. Br J Clin Pharmacol 89(2):921. https://doi.org/10.1111/bcp.15593
Verbalis JG, Greenberg A, Burst V et al (2016) Diagnosing and treating the syndrome of inappropriate antidiuretic hormone secretion. Am J Med 129(5):537.e9-e23. https://doi.org/10.1016/j.amjmed.2015.11.0053
Zerbe R, Stropes L, Robertson G (1980) Vasopressin function in the syndrome of inappropriate antidiuresis. Annu Rev Med 31:315–327. https://doi.org/10.1146/annurev.me.31.020180.001531
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No conflict of interest was declared.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Tanemoto, M. Vasopressin V2 receptor antagonists for the syndrome of inappropriate antidiuretic hormone secretion. Int Urol Nephrol 56, 361–362 (2024). https://doi.org/10.1007/s11255-023-03643-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-023-03643-9